A more recent study from Retina Implant showed even greater promise, with videos showing one
previously blind patient who could identify apples and bananas, and who could tell when his name had been misspelled.
CT - P13 has
previously demonstrated pharmacokinetic (PK) equivalence to INX in the PLANETAS trial, a randomised double -
blind, parallel group study of 250
patients with AS, and was recently approved by the European Medicines Agency.